Tectonic Therapeutic, Inc.
TECX
$15.64
$0.583.85%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -57.71% | -4.50% | -57.24% | -76.22% | -21.20% |
| Total Depreciation and Amortization | 1.19% | -4.51% | 36.19% | 14.29% | -9.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 41.67% | -2.83% | 258.44% | 252.16% | 305.62% |
| Change in Net Operating Assets | 153.35% | -105.24% | -49.36% | -760.84% | -1,585.13% |
| Cash from Operations | -9.99% | -41.09% | -44.30% | -131.15% | -37.56% |
| Capital Expenditure | -100.00% | -575.00% | 94.00% | -2,085.71% | 104.65% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 1,275.00% | -575.00% | 94.00% | -2,085.71% | 104.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.82% | 0.00% | 0.00% | -5.26% | 3.17% |
| Issuance of Common Stock | -91.82% | 4,455,900.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -114.50% | -- | -- | -- | -- |
| Cash from Financing | -102.32% | 26,764.97% | -103.13% | -5,414.91% | 142,749.21% |
| Foreign Exchange rate Adjustments | -300.00% | 93.42% | 131.25% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -111.34% | 1,746.61% | -179.58% | -202.59% | 1,773.80% |